Disclosure Of Entity's Operating Segments [Text Block]

GenSight Biologics S.A. - Filing #2810901

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	1,267,000 EUR	—	—	—	—	—	—	—	—	2,582,000 EUR	—
Tax expense (income)	—	0 EUR	—	—	—	—	—	—	—	—	5,000 EUR	—
Profit (loss)	— EUR	26,220,000 EUR	26,220,000 EUR	—	— EUR	— EUR	—	— EUR	— EUR	27,625,000 EUR	27,625,000 EUR	— EUR
Assets	—	—	—	9,132,000 EUR	—	—	25,941,000 EUR	—	—	—	—	—
Cash flows from (used in) operating activities	—	24,663,000 EUR	—	—	—	—	—	—	—	—	33,753,000 EUR	—
Cash flows from (used in) investing activities	—	209,000 EUR	—	—	—	—	—	—	—	—	172,000 EUR	—
Cash flows from (used in) financing activities	—	15,859,000 EUR	—	—	—	—	—	—	—	—	95,000 EUR	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]